ChemMedChem · 2010 · 32 citations · 25 references
PharmacyChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsEnzyme InhibitionHit-to-lead OptimizationLead Compound DesignLigand BindingMolecular DockingProtein-ligand DockingActivity Relationship AnalysisBiological Evaluation ReportChemical Synthesis Of AnaloguesMedicinal Chemistry ApplicationsMolecular Docking Of InhibitorsStructure - Activity Relationship OptimizationStructure-activity Relationship Modeling
A small set of aggrecanase inhibitors based on the pyrrolo[3,4-c]quinolin-1-one or oxoisoindoline frameworks bearing a 4-(benzyloxy)phenyl substituent and different zinc binding groups were rationally designed and evaluated in silico by docking studies using the crystal structure of the ADAMTS-5 catalytic domain (PDB code: 3B8Z). The designed compounds were synthesized via straightforward routes and tested for their potential inhibitory activity against ADAMTS-5 and ADAMTS-4. Among the compounds containing the pyrrolo[3,4-c]quinolinone tricyclic system, hydroxamate derivative 2 b inhibited both ADAMTS-5 and ADAMTS-4, with IC(50) values in the submicromolar range and an inhibitory profile very similar to that of reference carboxylate derivative 11. Conversely, the corresponding carboxylate derivative 2 a was significantly less active and unable to discriminate between ADAMTS-5 and -4. The structure-activity relationship analysis of pyrroloquinolinone derivatives 2 a-i suggests that the carboxylate or hydroxamate groups of compounds 2 a,b play a key role in the interaction of these compounds with ADAMTS-5 and -4. On the other hand, the oxoisoindoline derivatives 3 a,b lack significant ADAMTS-4 inhibitory activity and inhibit ADAMTS-5 showing IC(25) values in the micromolar range.
25
Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis
S.S. Glasson, Roger Askew, Barbara Sheppard et al. · Nature · 2005 · 1.3K citations
ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro
Heather Stanton, Fraser M. Rogerson, Charlotte J. East et al. · Nature · 2005 · 915 citations
Michael W. Lark, E K Bayne, J. Flanagan et al. · Journal of Clinical Investigation · 1997 · 472 citations · Full text